scorecardresearch
Add as a preferred source on Google
Saturday, September 27, 2025
TopicBiocon

Topic: Biocon

Serum Institute to double investment in Biocon’s unit to $300 million

Under new terms of the alliance, it would pump in $150 million after converting a loan to Biocon Pharma Ltd into equity in Biocon Biologics Ltd, the company said.

CBI alleges bribery in Biocon injection clearance, company says ‘approvals legitimate’

In a statement Monday, Biocon Biologics spokesperson said the injection is approved in Europe & many other countries. CBI has booked joint drug controller, Biocon executives in the case.

Biocon partners SII to make vaccine, drug manufacturing accessible to developing nations

Under the deal, Biocon Biologics Ltd (BBL) will offer approximately 15% stake to Serum Institute Life Sciences at a post-money valuation of about Rs 35,000 crore.

Biocon Biologics joins Novartis, Pfizer to distribute cancer drugs in lower-income countries

Biocon Biologics partnered with international organisations to enhance access to life-saving cancer drugs for patients, especially in Sub-Saharan and Asian regions.

Monitor efficacy of Itolizumab, not just safety, in Covid trials — expert panel tells Biocon

Govt's expert panel, that advises the apex drug regulator, has asked Biocon to submit a revised proposal for phase 4 trials of Itolizumab, which already has emergency use approval.

In Covid quarantine, Netflix, Amazon Prime were my constant companions: Kiran Mazumdar Shaw

I was expecting the infection to be mild and short-lived. My Covid-19 experience has matched these expectations and I hope that it allays the fear of the virus.

Biocon to give more data on Itolizumab to Covid task force after its rejection for treatment

The company said it would share more data as ‘evidence’, which it has derived from off-label use of the drug on 1,000 patients.

Task force decides against including Itolizumab in clinical management protocols for Covid

Itolizumab was approved for 'restricted emergency use' in the treatment of coronavirus by the Drugs Controller General of India (DCGI) recently.

30 patients, 2 months — how Biocon claims to have found a Covid hope in itolizumab

The drug controller general of India (DCGI) had Saturday approved Biocon’s itolizumab for emergency, restricted use among severe Covid-19 patients.

All about Biocon’s Itolizumab, psoriasis drug approved for emergency use in Covid patients

DGCI has given 'restricted emergency use' approval to the drug for treating Covid-19 patients with moderate-to-severe acute respiratory distress.

On Camera

Cambodia isn’t ready for India’s tigers. It doesn’t have prey or protection for big cats

Data from one comprehensive survey of the relocation landscape by the US-based Global Conservation shows that there is simply not enough large-bodied prey—a prerequisite for tigers—in the intended release area.

Market regulator SEBI clears Adani Group of impropriety alleged by Hindenburg Research

SEBI probe concluded that purported loans and fund transfers were paid back in full and did not amount to deceptive market practices or unreported related party transactions.

With MiG-21’s exit, India’s squadron strength hits 6-decade low. What are IAF’s plans for the Tejas

While the IAF remains committed to the Tejas programme and has placed orders for 180 Tejas Mk1A, the force is eagerly waiting for the Tejas Mk 2 version.

Something’s hidden in the Oval Office photo of Trump, Munir, Sharif. India must look closely

What Munir has achieved with Trump is a return to normal, ironing out the post-Abbottabad crease. The White House picture gives us insight into how Pakistan survives, occasionally thrives and thinks.